Pharma Marketing Network

Continuing Medical Education (CME) in Europe has undergone some major shifts in recent years. These have varied across Europe: from national changes in which systems have moved from being voluntary to mandatory, to the establishment of more formal systems to guide physicians on how to keep up-to-date with latest clinical practice. This article, written two European CME consultants, provides an overview of the state of CME in the UK, France, and other European countries.

This year is proving to be a critical one for many industries, including the pharma-ceutical industry. Actionable, evidence-based and global pharmaceutical competitive intelligence (CI) and general business intelligence (BI) will play an important role in the drama about to unfold. This article highlights several presentations made at the 2008 Pharmaceutical Competitive Intelligence Conference and discusses some common themes, including how environments for the pharmaceutical and device industries are changing dramatically with implications for CI going forward, the importance of keeping an eye on China, and whether CI is a strategic or tactical discipline.

Medical device marketing is different than Rx drug marketing, which is something attendees of the recent PharmaMed Marketing & Media Conference hosted by Med Ad News learned. This article summarizes a presentation from that conference and discusses how medical device marketing to consumers and physicians is different than Rx drug marketing. While some device marketing campaigns take a page from the Rx arena, there are difficulties and roadblocks ahead and these are also summarized in this article.

It's official! If the presidential election were held today, 55 percent of employees of pharmaceutical companies said they would vote for Mr. Obama and 28 percent said they would vote for Mr. McCain.

There is no doubt that the next several years will be very tough on the pharmaceutical industry.

Welcome to the October, 2008 issue of Pharma Marketing News.

Welcome to the October, 2008 issue of Pharma Marketing News.

In last night's episode of Boston Legal, a TV show, Denny Crane -- the senior partner at Crane Poole & Schmidt played by William...

While everyone was focused on the $700 billion proposal to bailout Wall Street, hardly anyone noticed the $25-$50 billion bailout of the automobile industry...

I spent yesterday in New York City attending the 2008 Doctors' Choice Awards ceremony at the posh Palace Hotel (see my previous post about...